Naunyn-Schmiedeberg's Archives of Pharmacology

, Volume 338, Issue 5, pp 484–488 | Cite as

Relaxant effect of dopamine on the isolated rat uterus

  • L. Estañ
  • I. Martinez-Mir
  • E. Rubio
  • F. J. Morales-Olivas


The effect of dopamine was studied on the isolated uterus of diethylstilboestrol-treated rats. Dopamine, at concentrations (107–10−4 M) produced a concentration-dependent relaxation in the K+-depolarized rat uterus. On a molar basis, dopamine was about 500 times less potent than adrenaline in relaxing the uterus, the maximum degree of relaxation obtained with both drugs was the same. Pretreatment of the rats with reserpine (5 mg/kg) did not produce any modification of the dose-response curve to dopamine. Similarly, cocaine (3 × 10−6 M) failed to modify the relaxant effect of dopamine. The dopamine induced relaxation was inhibited by propranolol (10−9–10−7 M) in a dose-dependent manner. Prazosin (10−7 M), SCH 23390 (10−7 M) and sulpiride (10−7 M) did not affect the dopamine dose-response curve. In the isolated rat uterus which was not preconstricted by KCl neither dopamine nor adrenaline produced any effect when added to the organ bath. This lack of response to both catecholamines was present even in tissues pretreated with propranolol or sulpiride. It is concluded that dopamine produced a concentration-dependent relaxation of the uterus from diethylstilboestrol-treated rats by direct activation of beta-adrenoceptors. There was no evidence for indirect action (catecholamine release and neuronal uptake mechanisms) and specific dopamine receptor mediated relaxation and alpha-adrenoceptor mediated contractions have not been found in this preparation.

Key words

Isolated rat uterus Dopamine Catecholamine Beta adrenoceptors 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Advenier C, Saint-Aubin A, Mallard B, Boissier JR (1980) Bronchopulmonary effects of dopamine in the guinea-pig. Arch Int Pharmacodyn 243:261–274PubMedGoogle Scholar
  2. Aguilar MJ, Morales-Olivas FJ, Rubio E (1986) Pharmacological investigation into the effects of histamine and histamine analogues on guinea-pig and rat colon in vitro. Br J Pharmacol 88:501–506CrossRefGoogle Scholar
  3. Arunlakshana O, Schild HO (1959) Some quantitative uses of drug antagonists. Br J Pharmacol Chemother 14:48–58CrossRefGoogle Scholar
  4. Bogaert MG, Buylaert WA, Lefebvre RA, Willems JL (1984) Peripheral dopamine receptors. In: Poste G, Crooke ST (eds) Dopamine receptor agonists. Plenum Press, New York London, pp 139–155CrossRefGoogle Scholar
  5. Borda E, Agostini MC, Sterin-Borda L, Gimeno MF, Gimeno AL (1981) Inhibitory effects of some catecholamines on contractions of uterine strips isolated from estrous and spayed rats. Influence of endogenous and exogenous prostaglandins on the action of methoxamine. Eur J Pharmacol 69:55–62CrossRefGoogle Scholar
  6. Boyle FC, Digges KG (1982) Response to catecholamines of the rat isolated uterus throughout the natural oestrous cycle. Naunyn-Schmiedeberg's Arch Pharmacol 321:56–62CrossRefGoogle Scholar
  7. Cheng HC, Woodward JK (1984) Mouse uterine muscle as a model for studying beta-2 adrenoceptors mediated relaxation. J Anton Pharmacol 4:17–25CrossRefGoogle Scholar
  8. Chow EHM, Marshall JM (1981) Effects of catecholamines on circular and longitudinal uterine muscle of the rat. Eur J Pharmacol 76:157–165CrossRefGoogle Scholar
  9. Cortijo J, Esplugues J, Morcillo E, Perpiña M (1984a) Pharmacological analysis of the responsiveness of guinea-pig lung parenchymal strip to dopamine. Br J Pharmacol 83:161–167CrossRefGoogle Scholar
  10. Cortijo J, Esplugues J, Morales-Olivas FJ, Rubio E (1984b) The inhibitory effect of histamine on the motility of rat uterus in vivo. Eur J Pharmacol 97:7–12CrossRefGoogle Scholar
  11. Digges KG (1982) Adrenoceptors in uterus. J Anton Pharmacol 2:53–67CrossRefGoogle Scholar
  12. Estañ L, Morales-Olivas FJ, Rubio E, Esplugues J (1985) Effect of methoxamine on spontaneous motility of the isolated rat uterus. Gynecol Obstet Invest 19:53–56CrossRefGoogle Scholar
  13. Golberg LI (1972) Cardiovascular and renal actions of dopamine: potential clinical applications. Pharmacol Rev 24:1–29Google Scholar
  14. Golberg LI, Voldman PH, Kohli JD (1978) A comparison of the vascular dopamine receptors with other dopamine receptors. Ann Rev Pharmacol Toxicol 18:57–79CrossRefGoogle Scholar
  15. Hartley M, Pennefather JN (1981) The response of the costo-uterine muscle of the rat to adrenoceptor agonists during the oestrous cycle: a comparison with the uterine horn. J Auton Pharmacol 1:133–140CrossRefGoogle Scholar
  16. Hilditch A, Drew GM, Naylor RJ (1984) SCH 23390 is a very potent and selective antagonist at vascular dopamine receptors. Eur J Pharmacol 97:333–334CrossRefGoogle Scholar
  17. Imbs JL, Schmidt M, Schwartz J (1983) Caractéristiques pharmacologiques des recepteurs dopaminergiques rénaux: perspectives therapeutiques. J Pharmacol 14:5–27PubMedGoogle Scholar
  18. Koga Y, Downes H, Taylor SM (1980) Direct and indirect actions of dopamine on tracheal smooth muscle. Naunyn-Schmiedeberg's Arch Pharmacol 315:15–20CrossRefGoogle Scholar
  19. Lackovic Z, Kleinman J, Karoun F, Ineff NH (1981) Dopamine and its metabolites in human peripheral nerves: is there a widely distributed system of peripheral nerves? Life Sci 29:917–922CrossRefGoogle Scholar
  20. Lokhandwala MF, Barrett RJ (1982) Cardiovascular dopamine receptors: Physiological, pharmacological and therapeutic implications. J Auton Pharmacol 3:189–211CrossRefGoogle Scholar
  21. Lumley P, Broadley KJ (1977) Evidence from agonist and antagonist studies to suggest that the beta-1 adrenoceptors subserving the positive inotropic and chronotropic response of the heart do not belong to two separate subgroups. J Pharm Pharmacol 29:598–604CrossRefGoogle Scholar
  22. Martinez-Mir I, Morales-Olivas FJ, Rubio E (1987) The lack of the effect of DA-1 and DA-2 dopamine agonists on the isolated guinea-pig atria. J Anton Pharmacol 7:111–117CrossRefGoogle Scholar
  23. Mugelli A, Ledda F, Mantelli L, Torrini M, Maccioni T (1977) Studies of the positive effect of the dopamine in the guinea-pig heart. Naunyn-Schmiedeberg's Arch Pharmacol 301:49–55CrossRefGoogle Scholar
  24. O'Donnell SR, Persson CGA, Wanstall JC (1978) An in vitro comparison of beta adrenoceptor stimulants on potassium-depolarized uterine preparations from guinea-pigs. Br J Pharmacol 62:227–233CrossRefGoogle Scholar
  25. Rubio E, Morales-Olivas FJ, Morcillo E, Esplugues J (1982) Indirect sympathomimetic effect of some H2-histamine receptor antagonists in the isolated uterus of the rat. J Pharm Pharmacol 34:740–741CrossRefGoogle Scholar
  26. Ruffolo RR, Messick K, Horng JJ (1984) Interactions of three inotropic agents, ASL-7022, dobutamine and dopamine, with alpha- and beta-adrenoceptors in vitro. Naunyn-Schmiedeberg's Arch Pharmacol 326:317–326CrossRefGoogle Scholar
  27. Simon A, Maanen EF (1971) Apomorphine and phentolamine antagonism of dopamine and norepinephrine. Fed Proc 30:624Google Scholar
  28. Simon A, Maanen EF (1976) Dopamine receptors and dopaminergic nerves in the vas deferens of the rat. Arch Int Pharmacodyn Ther 222:4–15PubMedGoogle Scholar
  29. Wagner J, Schumann HJ, Knorr A, Rohm N, Reidemeister JC (1980) Stimulation by adrenaline and dopamine but not by noradrenaline of myocardial alpha-adrenoceptor mediating positive inotropic effects in human atrial preparations. Naunyn-Schmiedeberg's Arch Pharmacol 312:99–102CrossRefGoogle Scholar

Copyright information

© Springer-Verlag 1988

Authors and Affiliations

  • L. Estañ
    • 1
  • I. Martinez-Mir
    • 1
  • E. Rubio
    • 1
  • F. J. Morales-Olivas
    • 1
  1. 1.Departament de Farmacologia i Farmacotecnia, Facultat de MedicinaUniversitat de ValenciaValenciaSpain

Personalised recommendations